Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SGYP > SEC Filings for SGYP > Form 8-K on 22-Oct-2012All Recent SEC Filings

Show all filings for SYNERGY PHARMACEUTICALS, INC.

Form 8-K for SYNERGY PHARMACEUTICALS, INC.


22-Oct-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On October 22, 2012, Synergy Pharmaceuticals Inc. (the "Company") issued a press release announcing that on October 19, 2012, it initiated oral dosing of healthy adult volunteers in a Phase I clinical trial of SP-333, a guanylate cyclase C agonist designed to treat ulcerative colitis. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit
No. Description

99.1 Press release of Synergy Pharmaceuticals Inc., dated October 22, 2012

  Add SGYP to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SGYP - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.